Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use

International Journal of Clinical Pharmacy
Amna Al-HasharMohammed Al Za'abi

Abstract

Background Adverse drug events from preventable medication errors can result in patient morbidity and mortality, and in cost to the healthcare system. Medication reconciliation can improve communication and reduce medication errors at transitions in care. Objective Evaluate the impact of medication reconciliation and counselling intervention delivered by a pharmacist for medical patients on clinical outcomes 30 days after discharge. Setting Sultan Qaboos University Hospital, Muscat, Oman. Methods A randomized controlled study comparing standard care with an intervention delivered by a pharmacist and comprising medication reconciliation on admission and discharge, a medication review, a bedside medication counselling, and a take-home medication list. Medication discrepancies during hospitalization were identified and reconciled. Clinical outcomes were evaluated by reviewing electronic health records and telephone interviews. Main outcome measures Rates of preventable adverse drug events as primary outcome and healthcare resource utilization as secondary outcome at 30 days post discharge. Results A total of 587 patients were recruited (56 ± 17 years, 57% female); 286 randomized to intervention; 301 in the standard care group. In ...Continue Reading

References

Sep 27, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Almut G WintersteinRichard Segal
Feb 1, 2003·Annals of Internal Medicine·Alan J ForsterDavid W Bates
Mar 8, 2003·JAMA : the Journal of the American Medical Association·Jerry H GurwitzDavid W Bates
Nov 16, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kristine M GleasonGary A Noskin
Mar 2, 2005·Archives of Internal Medicine·Patricia L CornishEdward E Etchells
Apr 29, 2005·Journal of General Internal Medicine·Alan J ForsterDavid W Bates
Sep 15, 2005·Archives of Internal Medicine·Eric A ColemanSung-joon Min
Mar 15, 2006·Archives of Internal Medicine·Jeffrey L SchnipperDavid W Bates
Sep 27, 2006·Archives of Internal Medicine·Eric A ColemanSung-Joon Min
May 6, 2008·The Journal of Clinical Hypertension·Donald E MoriskyHarry J Ward
Apr 24, 2009·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Bruce E KoehlerAndrew L Masica
Nov 20, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kate Traynor
May 5, 2010·The American Journal of Geriatric Pharmacotherapy·Kathleen Tschantz UnroeCathleen Colón-Emeric
Feb 15, 2011·European Journal of Clinical Pharmacology·Lina M HellströmTommy Eriksson
May 31, 2012·Drugs & Aging·Eva TopinkováPierre-Olivier Lang
Jun 9, 2012·Pharmacoepidemiology and Drug Safety·Antonio Pintor-MármolMaria José Faus
Jul 4, 2012·Annals of Internal Medicine·Sunil KripalaniUNKNOWN PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group
Aug 9, 2012·Annals of Saudi Medicine·Sami Ali Al-GhamdiHisham Saad Aljadhey
Aug 9, 2012·The Annals of Pharmacotherapy·Katherine Taylor HaynesSunil Kripalani
Feb 16, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·UNKNOWN Developed through the ASHP Council on Pharmacy Practice and approved by the ASHP Board of Directors on April 13, 2012, and b
Jun 14, 2013·BMC Geriatrics·Frank Wan-kin ChanCarmen Ka-man Wong
Aug 24, 2013·Journal of Patient Safety·Ché Matthew HarrisScott Wright
Nov 22, 2013·The Annals of Pharmacotherapy·Mitchell S BuckleySandra L Kane-Gill
Feb 12, 2014·International Journal of Clinical Pharmacy·T Michael FarleyBarry L Carter
Jul 23, 2014·The Annals of Pharmacotherapy·Elin C LehnbomJohanna I Westbrook
Oct 16, 2015·Medicine·Géraldine Leguelinel-BlacheAlbert Sotto
Feb 18, 2016·Journal of General Internal Medicine·Susan P BellUNKNOWN Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) Study Group
Feb 26, 2016·Journal of Pharmacy Practice·Samantha AxtellJamie Fairclough
Nov 9, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jeffrey L Schnipper, Stephanie Labonville

❮ Previous
Next ❯

Citations

Mar 22, 2019·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Aline F BonettiRoberto Pontarolo
Mar 4, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fatema A AlqenaeRichard N Keers
Jun 14, 2020·Research in Social & Administrative Pharmacy : RSAP·Sara DaliriFatma Karapinar-Çarkit
Nov 12, 2020·Journal of Multidisciplinary Healthcare·Ting ZhangFushan Tang
Nov 27, 2020·Therapeutic Advances in Drug Safety·Elizabeth ManiasAngela Wu
Sep 16, 2021·International Journal of Clinical Practice·Carmela Bou MalhamPascale Salameh
Nov 26, 2021·The Cochrane Database of Systematic Reviews·Agustín CiapponiEzequiel Garcia-Elorrio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.